Clinical Trial Update: Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing maintenance versus observation after six cycles of gemcitabine plus paclitaxel in patients with advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Samsung Medical Center | Conditions: Advanced Breast Cancer | Phase 3 | Status: COMPLETED